REQUEST A DEMO
Total
USD $0.00
Search more companies

Swixx Biopharma S.R.L. (Romania)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Swixx Biopharma S.R.L. Profile Updated: February 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Swixx Biopharma S.R.L. is a company based in Romania, with its head office in Bucharest. The company operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was first established on July 16, 2018. 30 (2025) employees currently work for Swixx Biopharma S.R.L.. From the latest financial highlights, Swixx Biopharma S.R.L. reported a net sales revenue increase of 46.16% in 2024. During that time, Swixx Biopharma S.R.L.’s total assets grew by 7.4%. Swixx Biopharma S.R.L.’s net profit margin increased by 3.21% in 2024.

Headquarters
Soseaua Bucuresti-Ploiesti Nr. 1a
Bucharest; Bucharest; Postal Code: 011857

Contact Details: Purchase the Swixx Biopharma S.R.L. report to view the information.

Basic Information
Total Employees:
Purchase the Swixx Biopharma S.R.L. report to view the information.
Registered Capital:
Purchase the Swixx Biopharma S.R.L. report to view the information.
Financial Auditors:
Purchase the Swixx Biopharma S.R.L. report to view the information.
Incorporation Date:
July 16, 2018
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Swixx Biopharma S.R.L. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
46.16%
Total Operating Revenue
46.14%
Operating Profit
201.31%
EBITDA
195.77%
Net Profit/Loss for the Period
259.43%
Total Assets
7.4%
Total Equity
108.57%
Operating Profit Margin
5.98%
Net Profit Margin
3.21%
Return on Equity (ROE)
21.85%
Quick Ratio
0.32%
Cash Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?